SCM
EXAS

Soleus Capital Management’s Exact Sciences EXAS Stock Holding History

Soleus Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-91,611
Closed -$3.87M – 90
2024
Q2 		$3.87M Buy
+91,611
New +$5.04M 0.34% 66
2023
Q4 		– Sell
-102,196
Closed -$6.97M – 88
2023
Q3 		$6.97M Buy
102,196
+32,696
+47% +$2.77M 0.64% 45
2023
Q2 		$6.53M Sell
69,500
-387,000
-85% -$30.2M 0.73% 40
2023
Q1 		$31M Buy
456,500
+169,200
+59% +$10.9M 3.21% 6
2022
Q4 		$14.2M Buy
287,300
+142,500
+98% +$5.82M 2.04% 18
2022
Q3 		$4.71M Buy
144,800
+25,800
+22% +$1.06M 0.64% 45
2022
Q2 		$4.69M Buy
+119,000
New +$6.36M 0.73% 42

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Soleus Capital Management's EXAS Position: Q3 2024 in Review

Soleus Capital Management sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 91,611 shares — an estimated $3.87M sold.

Soleus Capital Management first reported a position in EXAS in Q2 2022 and held it in 7 quarters. The position peaked at $31M in Q1 2023. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Soleus Capital Management reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Soleus Capital Management sold 91,611 Exact Sciences shares in Q3 2024, an estimated $3.87M.
  • Soleus Capital Management first reported a position in Exact Sciences in Q2 2022 and held it in 7 quarters.
  • Soleus Capital Management's Exact Sciences position peaked at $31M in Q1 2023.
  • 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Soleus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.